Skip to main content
BIIB $209.83 -0.39%
BIIB logo

BIIB · Biogen Inc.

Track BIIB — free
$209.83 -0.82 (-0.39%) At close · Aug 14
Market Cap
$30.98B
Shares
147.64M
All earnings calls

Earnings call · FY2019 Q4

Biogen Inc. Q4 FY2019 Earnings Call

Biogen Inc. Q4 FY2019 Earnings Call

Concluded Jan 30, 2020
Jan 30, 2020 0 turns
Period
FY2019 Q4
Runtime
Sources
2 artifacts

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Research coverage

2 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $3.67B +4.1% YoY
Diluted EPS $8.08 +70.8% YoY
Gross margin 87.8% +1.7 pp YoY
Net income $1.44B +52.1% YoY

Research materials

Open the source you need; every reader stays inside this workspace.

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Product$2.92B +3.5% YoY
Revenuesfromanticd20therapeuticprograms$600.80M +12.3% YoY
Product And Service Other$145.70M -12.1% YoY
Full-screen source Call document